Zobrazeno 1 - 2
of 2
pro vyhledávání: '"H. H. Bhavana"'
Autor:
Raghu Ram Achar, Chandan Shivamallu, Pallavi M, P. Ashwini, S. Bindya, Sharanagouda S. Patil, Chandrashekar Srinivasa, Kollur Shiva Prasad, H. H. Bhavana, H. S. Vikas, Bhargav Shreevatsa, Chandan Dharmashekara, Gayatri Vaidya, Akshatha C
Publikováno v:
Journal of Pharmaceutical Research International. :879-891
COVID-19's recent appearance in Wuhan, China, has affected more than three million twenty-five million individuals worldwide. It is considered a pandemic disease by WHO. Till now, there is no approved therapeutic for treating COVID-19 infection. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f553d461f4d9cd63037711b97d878c44
https://doi.org/10.9734/jpri/2021/v33i60b34690
https://doi.org/10.9734/jpri/2021/v33i60b34690
Autor:
Chandan Shivamallu, Ashwini Prasad, Raghu Ram Achar, Kuralayanapalya Puttahonnappa Suresh, Sharanagouda S. Patil, Shiva Prasad Kollur, S. M. Gopinath, Chandrashekar Srinivasa, H. H. Bhavana, Bhargav Shreevatsa, Gayatri Vaidya, Sabhyata M. Gopal, Chandan Dharmashekara
Publikováno v:
Journal of Pharmaceutical Research International. :400-410
Background: Leptospirosis is a disease that is zoonotic in nature. It is easily able to survive in the environment and gets transmitted from the reservoir hosts such as rat to humans. Though the cause of Leptospira interrogans virulency is not determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4653f1572ed5bdbda25acc81959f758
https://doi.org/10.9734/jpri/2021/v33i60b34635
https://doi.org/10.9734/jpri/2021/v33i60b34635